A phase I study of LY3410738, a first-in-class covalent inhibitor of mutant IDH1 in cholangiocarcinoma and other advanced solid tumors Meeting Abstract
| Authors: | Pauff, J. M.; Papadopoulos, K. P.; Janku, F.; Turk, A. A.; Goyal, L.; Shroff, R. T.; Shimizu, T.; Ikeda, M.; Azad, N. S.; Cleary, J. M.; Peters, M. L. B.; Borad, M. J.; Jaeckle, K. A.; Kizilbash, S. H.; Tupper, R.; Furin, C. E.; Hanley, M. P.; Hill, E. G.; Xu, X.; Harding, J. J. |
| Abstract Title: | A phase I study of LY3410738, a first-in-class covalent inhibitor of mutant IDH1 in cholangiocarcinoma and other advanced solid tumors |
| Meeting Title: | 2021 Gastrointestinal Cancers Symposium (ASCO GI) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 15-17 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-01-20 |
| Language: | English |
| ACCESSION: | WOS:000636712800035 |
| DOI: | 10.1200/JCO.2021.39.3_suppl.TPS350 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS350 -- Source: Wos |
